ABBV-303 Is an NK-cell Engager Specific for c-Met–Expressing Tumors
Year: 2025
Type: article
Source: Cancer Research
Institutions: AbbVie (United States), Purdue University West Lafayette
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: AbbVie
OpenAlex ID: W4415628437
